Top Markets
#1 Siacoin Siacoin +14.86%
#2 Cash Cat Cash Cat +14.42%
#3 Seeker Seeker +10.67%
#4 DogBull DogBull +10.03%
#5 0G 0G +8.40%
#6 Arbitrum Arbitrum +8.06%
#7 Metis Metis +4.91%
#8 StonkBroker StonkBroker +4.59%
#9 Akedo Akedo +4.29%
#10 Story Story +4.17%
Coin of the day
Siacoin Siacoin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
EirGenix Inc. EirGenix Inc.

EirGenix Inc.

6589
Kedudukan dalam Saham #14109
EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions... EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions as a contract development and manufacturing organization (CDMO) with operations spanning both domestic and international markets. The company offers a comprehensive range of services, encompassing cell line creation, process optimization, analytical testing and quality control, and current Good Manufacturing Practice (cGMP) compliant production utilizing both mammalian and microbial expression systems. They also specialize in services related to antibody-drug conjugates (ADCs). Beyond its service offerings, EirGenix is actively engaged in developing several therapeutic candidates. This pipeline includes EG12014/EGI014, a Trastuzumab biosimilar intended for cancer therapy, which has reached the biologics license application (BLA) submission stage. Other oncology-focused developments are EG1206A, a Pertuzumab biosimilar currently in Phase I clinical trials; EG13074, in preclinical development; and TSY0110(EG12043), an antibody-drug conjugate also in preclinical stages. Additionally, the company is advancing EG12021, a Bevacizumab biosimilar for cancer treatment, and EG62054, another biosimilar, both in preclinical development. In addition to its core activities, EirGenix manufactures and distributes a rapid antigen test for COVID-19, as well as the CRM197 carrier protein under the designation EG74032.
Harga Saham
$1.46
Disegerakkan terakhir: 2026-07-28
Modal Pasaran
$435.25M
Perubahan (1 hari)
-2.34%
Perubahan (1 tahun)
-25.65%
Negara
TW
Perdagangan EirGenix Inc. (6589)

Kategori

Healthcare
Sejarah dividen untuk EirGenix Inc. (6589)
EirGenix Inc. (simbol saham: 6589) telah membuat sejumlah 0 pembayaran dividen.
Jumlah semua dividen (disesuaikan untuk pemecahan saham): 0.00
Hasil dividen (TTM): 0
Pembayaran dividen untuk EirGenix Inc. (6589) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (diselaraskan untuk pemecahan saham) Ubah
Tidak cukup data untuk tarikh yang disediakan.
Senarai semua pembayaran dividen
Tahun Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pembayaran dividen untuk syarikat serupa atau pesaing
Syarikat Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH